GreensKeeper Asset Management’s third-quarter 2025 investor letter reported a +4.0% gain for the Value Fund, with a YTD return of +0.2% after fees. The US dollar’s impact led to a -3.7% performance decline. The market rally in 2025 was driven by AI, crypto, and speculation. Check their top 5 holdings for insights on 2025 picks.

Novo Nordisk A/S (NYSE:NVO) was highlighted in GreensKeeper Asset Management’s investor letter. The stock had a one-month return of -0.08% and lost 53.79% over 52 weeks. On December 16, 2025, NVO closed at $48.96 per share, with a market cap of $217.553 billion. The company’s guidance was lowered, citing competition and market factors.

GreensKeeper Asset Management’s letter discussed Novo Nordisk A/S (NYSE:NVO) as the second-largest detractor in the quarter, declining by -19.6%. The company’s challenges include market expansion, competition, and management changes. Despite potential, NVO was not among the 30 most popular stocks among hedge funds in 2024 Q3, with 50 portfolios holding it. AI stocks were favored for greater potential.

Read more at Yahoo Finance: Novo Nordisk (NVO) Hit By Lowered Guidance